Your session is about to expire
← Back to Search
Fiber Inulin for Chronic Obstructive Pulmonary Disease
Study Summary
This trial will compare changes in short chain fatty acid (SCFA) metabolism after inulin vs. placebo intake in COPD patients to healthy matched controls.
- Chronic Obstructive Pulmonary Disease (COPD)
- Aging
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You had a fever in the past three days.You have taken oral corticosteroids for a short period of time within the past 4 weeks before the study.You have been taking fiber supplements every day for a week before the first test day.You are allergic to inulin, maltodextrin, or any of the ingredients in the study.You have diabetes that requires insulin for treatment.If the doctor or nurse finds any other health condition during the screening visit that could affect your safety or the study, you may not be able to participate.You do not have a diagnosis of COPD (chronic obstructive pulmonary disease).You can comfortably lie down flat or with your upper body elevated for 1.5 hours.You have a history of untreated liver or kidney problems.You have a serious illness that is not stable or well-controlled.You have been taking protein supplements every day for the 5 days leading up to the test.You are allergic to inulin or products containing inulin.You have difficulty breathing when you do physical activities.You have been feeling well and haven't had a respiratory infection or worsening of your condition for at least 4 weeks before the first test day.
- Group 1: Chronic Obstructive Pulmonary Disease patients
- Group 2: Healthy Participants
- Group 3: Healthy Young Participants
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is enrollment for this research endeavor still open to the public?
"Correct. Information posted to clinicaltrials.gov confirms that this medical trial, first published on June 23rd 2020, is actively enrolling volunteers. Approximately 150 individuals are needed at 1 specified site for participation in the study."
How many individuals have been recruited to participate in this research endeavor?
"Affirmative. Clinicaltrials.gov's records imply that this medical trial is presently seeking participants, with the initial posting dated June 23rd 2020 and the latest update on December 10th 2021. One location needs to fill 150 positions for this project."
What are the key objectives of this trial?
"This trial, which will take place over a five-week period, intends to analyse intestinal microbiota composition by collecting stool samples with shallow shotgun sequencing. Secondary objectives include assessing state of mood through the Hospital Anxiety and Depression Scale (HADS), determining COPD impacts via self-administered questionnaire, and measuring bone mineral density through bioelectrical impedance analysis (BIA)."
Share this study with friends
Copy Link
Messenger